ClearPoint Neuro, Inc.
CLPT
Rank in Stocks
#14903
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within... ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
Share Price
$9.17
Last synced: 2026-11-09
Market Cap
$293.94M
Change (1 day)
6.63%
Change (1 year)
-47.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ClearPoint Neuro, Inc. (CLPT)
Category
Healthcare
EPS for ClearPoint Neuro, Inc. (CLPT)
EPS as of September 2026 TTM: $-1.21
According to ClearPoint Neuro, Inc.'s latest financial reports, its current EPS (TTM) is $-1.21. At the end of 2025 the company had an EPS of $-0.90, a decrease compared to its 2024 EPS of $-0.70.
EPS history for ClearPoint Neuro, Inc. from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.21 | 34.44% |
| 2025 | $-0.90 | 28.57% |
| 2024 | $-0.70 | -22.22% |
| 2023 | $-0.90 | 32.35% |
| 2022 | $-0.68 | -1.45% |
| 2021 | $-0.69 | 60.47% |
| 2020 | $-0.43 | -12.24% |
| 2019 | $-0.49 | -12.50% |
| 2018 | $-0.56 | -39.78% |
| 2017 | $-0.93 | -68.26% |
| 2016 | $-2.93 | -34.60% |
| 2015 | $-4.48 | 46.41% |
| 2014 | $-3.06 | -38.18% |
| 2013 | $-4.95 | -12.39% |
| 2012 | $-5.65 | -72.74% |
| 2011 | $-20.73 | -12.75% |
| 2010 | $-23.76 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -323.14% |
US
|
|
| $4.09 | -438.02% |
IE
|
|
| $9.45 | -880.99% |
US
|
|
| $2.37 | -295.87% |
US
|
|
| $1.77 | -246.28% |
US
|
Questions about ClearPoint Neuro, Inc.'s earnings per share (EPS)
What is ClearPoint Neuro, Inc.'s earnings per share (EPS)?
ClearPoint Neuro, Inc.'s earnings per share (EPS) over the last twelve months is $-1.21, as of Sep 2026.
What was ClearPoint Neuro, Inc.'s earnings per share (EPS) in 2025?
In 2025, ClearPoint Neuro, Inc.'s earnings per share (EPS) was $-0.90, compared with $-0.70 in 2024.
How has ClearPoint Neuro, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, ClearPoint Neuro, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.43) and lowest in 2025 ($-0.90).
How does ClearPoint Neuro, Inc.'s earnings per share (EPS) compare with similar companies?
ClearPoint Neuro, Inc.'s earnings per share (EPS) ($-1.21) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.